Verified against court and regulatory records · No upfront fees · Your information is never sold
Quick Eligibility Review
Answer one question at a time. This usually takes under 2 minutes.
Check your eligibility — free
Answer 2-3 quick questions to review your potential case.
Free · Confidential · About 2 minutes · A case specialist responds within 1 business day
Your answers are never sold or shared without your consent.
The testosterone therapy lawsuit names multiple defendants, each associated with specific TRT products. Identifying the correct defendant is important because settlement status, litigation posture, and available compensation pathways differ by manufacturer. AbbVie (AndroGel) has largely settled its MDL inventory. Eli Lilly (Axiron) and Actavis/Teva (Androderm) remain in active settlement discussions. Endo (Testim, Fortesta) requires a bankruptcy trust claim.
Pfizer's Depo-Testosterone — an injectable form — is the oldest TRT product and still widely prescribed. Pfizer's litigation exposure in MDL 2545 is smaller than AbbVie's given Depo-Testosterone's market share, but cases involving injectable testosterone are still being filed and evaluated. If you used any prescription testosterone product and suffered a cardiovascular injury, an attorney can identify the correct defendant and filing pathway for your specific situation.
The full investigation